Lack of correlation between Mbo I restriction fragment length polymorphism of renin gene and essential hypertension in Japanese. 2001

Y Fu, and T Katsuya, and T Asai, and M Fukuda, and N Inamoto, and Y Iwashima, and K Sugimoto, and H Rakugi, and J Higaki, and T Ogihara
Department of Geriatric Medicine, Osaka University Medical School, Suita, Japan.

Predisposition to essential hypertension is associated with gene polymorphisms of the renin angiotensin system (RAS). Gene polymorphisms of the angiotensinogen and angiotensin converting enzyme genes are known to be risk factors for hypertension, while few studies concerning the renin gene polymorphism have been published. In the present investigation, we carried out a case control study using a Japanese population to examine the genetic influence of the renin gene on the predisposition to hypertension. Patients (n=235) recruited from outpatients at Osaka University Hospital and diagnosed with essential hypertension or receiving long-term antihypertensive medication participated in the study. Normotensive control subjects (n=510) without a history of hypertension and without diabetes mellitus were recruited from the same population, and were sex-matched with experimental subjects. A polymorphism in intron 9 of the human renin gene was determined as the Mbo I restriction fragment length polymorphism (Mbo I-RFLP). There was no significant association between Mbo I-RFLP of the renin gene and predisposition to essential hypertension in Japanese (p>0.05, chi2=2.1). These results suggest that the Mbo I (+) allele of the renin gene does not increase the risk for hypertension in Japanese.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D005260 Female Females
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Y Fu, and T Katsuya, and T Asai, and M Fukuda, and N Inamoto, and Y Iwashima, and K Sugimoto, and H Rakugi, and J Higaki, and T Ogihara
August 1996, Polskie Archiwum Medycyny Wewnetrznej,
Y Fu, and T Katsuya, and T Asai, and M Fukuda, and N Inamoto, and Y Iwashima, and K Sugimoto, and H Rakugi, and J Higaki, and T Ogihara
January 1992, Clinical and experimental pharmacology & physiology. Supplement,
Y Fu, and T Katsuya, and T Asai, and M Fukuda, and N Inamoto, and Y Iwashima, and K Sugimoto, and H Rakugi, and J Higaki, and T Ogihara
June 1989, Human genetics,
Y Fu, and T Katsuya, and T Asai, and M Fukuda, and N Inamoto, and Y Iwashima, and K Sugimoto, and H Rakugi, and J Higaki, and T Ogihara
December 1989, Hypertension (Dallas, Tex. : 1979),
Y Fu, and T Katsuya, and T Asai, and M Fukuda, and N Inamoto, and Y Iwashima, and K Sugimoto, and H Rakugi, and J Higaki, and T Ogihara
January 1994, Hormone research,
Y Fu, and T Katsuya, and T Asai, and M Fukuda, and N Inamoto, and Y Iwashima, and K Sugimoto, and H Rakugi, and J Higaki, and T Ogihara
January 1983, Nature,
Y Fu, and T Katsuya, and T Asai, and M Fukuda, and N Inamoto, and Y Iwashima, and K Sugimoto, and H Rakugi, and J Higaki, and T Ogihara
December 1989, Arthritis and rheumatism,
Y Fu, and T Katsuya, and T Asai, and M Fukuda, and N Inamoto, and Y Iwashima, and K Sugimoto, and H Rakugi, and J Higaki, and T Ogihara
January 2002, Cancer detection and prevention,
Y Fu, and T Katsuya, and T Asai, and M Fukuda, and N Inamoto, and Y Iwashima, and K Sugimoto, and H Rakugi, and J Higaki, and T Ogihara
October 1993, Journal of human hypertension,
Y Fu, and T Katsuya, and T Asai, and M Fukuda, and N Inamoto, and Y Iwashima, and K Sugimoto, and H Rakugi, and J Higaki, and T Ogihara
January 2002, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!